Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer

This publication has 15 references indexed in Scilit:

• Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer
  The Journal of Steroid Biochemistry and Molecular Biology, 1988
• Medroxyprogesterone Acetate Pharmacokinetics Following Oral High‐Dose Administration in Humans: A Bioavailability Evaluation of a New MPA Tablet Formulation
  Acta Pharmacologica et Toxicologica, 1986
• Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects
  Journal of Pharmaceutical and Biomedical Analysis, 1983
• Enzymatic assay of medroxyprogesterone acetate in plasma
  The Journal of Steroid Biochemistry and Molecular Biology, 1980
• Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer
  Published by Elsevier ,1979
• Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma
  Acta Obstetricia et Gynecologica Scandinavica, 1979
• A mass fragmentographic method for the determination of megestrol acetate in plasma and its application to studies on the plasma levels after administration of the progestin to patients with carcinoma corporis uteri
  Journal of Steroid Biochemistry, 1974
• GLC Determination of Medroxyprogesterone Acetate in Plasma
  Journal of Pharmaceutical Sciences, 1974